Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Sym022 |
Trade Name | |
Synonyms | Sym 022|Sym-022 |
Drug Descriptions |
Sym022 is a monoclonal antibody that targets LAG3 and inhibits binding of MHC II molecules to increase cytokine production by T-cells and prevent tumor growth (AACR; Cancer Res 2018;78(13 Suppl):Abstract nr 5626). |
DrugClasses | Immune Checkpoint Inhibitor 149 LAG3 Antibody 18 |
CAS Registry Number | 2250088-52-7 |
NCIT ID | C156177 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Sym021 + Sym022 | Sym021 Sym022 | 0 | 1 |
Sym022 | Sym022 | 0 | 1 |